AL
Allarity Therapeutics, Inc.
ALLR · NASDAQ
$1.04 +0.00% (+$0.00)
1M -27.27%
Market Cap $16.5M
P/E Ratio -
Div. Yield -
ROE 152.77%
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Weak
1/9Valuation
21 /100
Expensive P/B 4.68x
P/S 47.96x
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 73.25%
Rev. growth N/A
FCF growth N/A
Profitability
20 /100
Weak Net margin 3,575.07%
Op. margin 3,128.99%
FCF margin 3,994.78%
Quality
0 /100
Poor ROE 152.77%
ROA 38.41%
Asset turnover 0.01x
Debt
10 /100
High Current ratio 1.11x
Int. coverage -10.36x
Debt/Equity 6.30x
Stability
76 /100
Stable EPS volatility 9.73%
Profitable years 0
Beta 0.56x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ALLR
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Thomas H. Jensen
Employees
8
Headquarters
Tarpon Springs
Prihajajoči dogodki
13 NOV.
Earnings
Upcoming earnings report